NASDAQ: DRTS
Alpha Tau Medical Ltd
Healthcare · Medical - Equipment & Services
Pre-market: $13.88(+0.07%) · as of 4:00 AM ET
Market Cap
$1.25B
52w High
$14.40
52w Low
$3.00
P/E
-20.70
Volume
497.95K
Outstanding Shares
90.33M
Price vs Fundamentals
Why The Stock Is Moving
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
What changed
The stock rose 326.77% over the last year.
What the market seems to be pricing
The stock has moved higher with no clear directional signal from operating metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
A decisive shift in revenue or cash flow over the next period would be the clearest signal to resolve the ambiguity.
Company profile
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer.
Valuation
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Analyst consensus
5
Buy
1
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Nov 24, 2026
Q4 FY26 · EPS est -$0.14 · Revenue est $368.25K
View